Assignee
TMEM16A LTD
GB·6 granted patents·2 pending applications·2 citations·filing 2019–2023
Top patents by PatentIndex Score
8 records- 0180US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 0261US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 0359US2024132467A1Benzimidazole derivatives for treating respiratory diseaseTMEM16A LTD·Filed 2023·Application pending·0 cites
- 0453US12552770B2Compounds for treating respiratory diseaseTMEM16A LTD·Filed 2021·Granted Feb 17, 2026·0 cites·8 claims
- 0553US12415793B2Modulators of TMEM16A for treating respiratory diseaseTMEM16A LTD·Filed 2021·Granted Sep 16, 2025·0 cites·13 claims
- 0650US12545658B2Pyridine derivatives as calcium-activated chloride channel modulatorsTMEM16A LTD·Filed 2022·Granted Feb 10, 2026·0 cites·1 claims
- 0749US2022235006A1Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditionsTMEM16A LTD·Filed 2022·Application pending·0 cites
- 0847US12281077B2Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]pyridine-2-carboxamideTMEM16A LTD·Filed 2022·Granted Apr 22, 2025·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →